# About — getgoodpeptides > About getgoodpeptides: an independent editorial desk for growth hormone axis research peptides — editorial method, literature standards, and independence. An independent editorial digest of peer-reviewed research on GH secretagogue peptides. Not a clinic, not a vendor, not a prescriber. ## What this desk is getgoodpeptides is an independent editorial desk. Its one job is to compile and summarize what the peer-reviewed research literature actually says about the four growth-hormone-axis research peptides it covers — ipamorelin, CJC-1295, sermorelin, and tesamorelin — and to report that research plainly and accurately, with citations. This is not a clinic, not a telehealth provider, not a vendor, and not a compounding pharmacy. The site has no financial relationship with any supplier, clinic, or promoter of these compounds. It does not sell products, make referrals, accept advertising from supplement or peptide vendors, or operate affiliate revenue arrangements. None of the content here constitutes medical advice, and no human dosing recommendations are made anywhere on the site. ## Editorial method Each compound page is built from peer-reviewed publications: randomized controlled trials, pharmacokinetics studies, mechanistic characterizations, and authoritative clinical reviews. Sources are cited by number throughout the text and aggregated on the [References](/references) page. A URL or DOI is provided for every source. Evidence is characterized by species and study type. When a finding comes from rats, that is stated. When a finding is from a single small human pharmacokinetics study, that is stated. When a result is from community or patient reports rather than controlled data, it is labeled explicitly as **"anecdotal, not clinical evidence."** The distinction matters and is never blurred. Where evidence is thin, inconclusive, or contradicted by editorial consensus — as with GH secretagogue anti-aging use — the desk says so plainly, with the citations that support the caution. Where a compound has a genuine regulatory history, positive or negative, that record is reported factually. ## Independence and disclaimer getgoodpeptides has no connection to any commercial party that sells, compounds, or markets the peptides discussed here. Content is compiled independently, updated periodically as new literature is published, and not influenced by any external interest. All content is for informational purposes only. The compounds covered are research-grade chemicals or (in tesamorelin's case) a prescription pharmaceutical intended for a specific approved indication. Nothing on this site should be interpreted as a recommendation to use, acquire, or administer any compound discussed. Regulatory status, evidence quality, and safety information described here reflect the peer-reviewed and regulatory literature at the time of publication; readers should consult appropriate clinical sources and licensed practitioners for any decisions regarding their own health. --- An independent literature digest of peer-reviewed research on the GH/IGF-1 axis — organized like a clinician's briefing, not a product catalog.